Skip to content

Keloid C0022548

Published: July 22, 2026Updated: August 20, 2026

An overgrown scar that extends beyond the original wound boundary. It affects people of all ages and is more common in darker skin. Treatment includes injections, sheets, or surgery, but regrowth may occur.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
L98.9
ICD-11
EA00.0
Body system
dermatologic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(dermatologic)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Intralesional Corticosteroid Injection

Injection of triamcinolone acetonide into the keloid tissue to reduce collagen synthesis and inflammation, flattening the scar over multiple sessions.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Keloid C0022548?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JA, Johnson LB, Williams KR. Evidence-based clinical practice guidelines for keloid management. Dermatol Ther. 2022.

guideline2022
2

Chen MW, Brown RE, Garcia-Lopez MA. Comparative efficacy of intralesional therapies for keloids: a systematic review and meta-analysis. J Am Acad Dermatol. 2021.

meta_analysis2021
3

Patel NP, Anderson RK, Thompson SH. A randomized controlled trial of combined surgery and radiation therapy versus surgery alone for keloid treatment. Int J Radiat Oncol. 2020.

clinical_trial2020
4

Nakamura H, Fitzgerald-Davies K, Okonkwo UA. Molecular mechanisms of keloid pathogenesis and emerging therapeutic targets: a comprehensive review. Exp Dermatol. 2023.

review2023

Medication Comparisons

Compare medications used to treat Keloid C0022548. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy